

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 4.86254382 |
| 2 | doxorubicin metabolic process (GO:0044598) | 4.86254382 |
| 3 | daunorubicin metabolic process (GO:0044597) | 4.86254382 |
| 4 | respiratory chain complex IV assembly (GO:0008535) | 4.83754703 |
| 5 | cytochrome complex assembly (GO:0017004) | 4.10359110 |
| 6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.97988519 |
| 7 | presynaptic membrane assembly (GO:0097105) | 3.94527833 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88573294 |
| 9 | platelet dense granule organization (GO:0060155) | 3.78084533 |
| 10 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.67681653 |
| 11 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.66813847 |
| 12 | lymphoid progenitor cell differentiation (GO:0002320) | 3.62093864 |
| 13 | superoxide anion generation (GO:0042554) | 3.60940663 |
| 14 | response to interferon-beta (GO:0035456) | 3.57225311 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 3.43531246 |
| 16 | presynaptic membrane organization (GO:0097090) | 3.35999239 |
| 17 | defense response to protozoan (GO:0042832) | 3.28289040 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.26370031 |
| 19 | mature B cell differentiation involved in immune response (GO:0002313) | 3.26176356 |
| 20 | GPI anchor biosynthetic process (GO:0006506) | 3.21273166 |
| 21 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.18629666 |
| 22 | protein localization to endosome (GO:0036010) | 3.15819868 |
| 23 | mature B cell differentiation (GO:0002335) | 3.15166013 |
| 24 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.10710720 |
| 25 | sodium ion export (GO:0071436) | 3.10484956 |
| 26 | detection of bacterium (GO:0016045) | 3.09881771 |
| 27 | NADH metabolic process (GO:0006734) | 3.06782671 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.03469792 |
| 29 | epoxygenase P450 pathway (GO:0019373) | 3.02911390 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.02550372 |
| 31 | lymph node development (GO:0048535) | 3.00574894 |
| 32 | definitive hemopoiesis (GO:0060216) | 2.99238348 |
| 33 | detection of other organism (GO:0098543) | 2.98749516 |
| 34 | mannosylation (GO:0097502) | 2.97342671 |
| 35 | mast cell activation (GO:0045576) | 2.97248323 |
| 36 | GPI anchor metabolic process (GO:0006505) | 2.96674753 |
| 37 | ethanol oxidation (GO:0006069) | 2.95892649 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.94835508 |
| 39 | complement activation, alternative pathway (GO:0006957) | 2.92168930 |
| 40 | regulation of activation of Janus kinase activity (GO:0010533) | 2.90093105 |
| 41 | regulation of ARF protein signal transduction (GO:0032012) | 2.88977824 |
| 42 | type I interferon signaling pathway (GO:0060337) | 2.87255631 |
| 43 | cellular response to type I interferon (GO:0071357) | 2.87255631 |
| 44 | adhesion of symbiont to host (GO:0044406) | 2.85433713 |
| 45 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.85164887 |
| 46 | response to type I interferon (GO:0034340) | 2.84810260 |
| 47 | cell communication by electrical coupling (GO:0010644) | 2.83771777 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81689567 |
| 49 | response to protozoan (GO:0001562) | 2.81193590 |
| 50 | cellular response to interferon-beta (GO:0035458) | 2.78254399 |
| 51 | creatine metabolic process (GO:0006600) | 2.72522456 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71958811 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71403077 |
| 54 | positive regulation of defense response to virus by host (GO:0002230) | 2.70752424 |
| 55 | detection of external biotic stimulus (GO:0098581) | 2.68740632 |
| 56 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.68556672 |
| 57 | signal peptide processing (GO:0006465) | 2.67692640 |
| 58 | axon ensheathment in central nervous system (GO:0032291) | 2.67517915 |
| 59 | central nervous system myelination (GO:0022010) | 2.67517915 |
| 60 | cellular potassium ion homeostasis (GO:0030007) | 2.67299508 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.66800017 |
| 62 | adenosine metabolic process (GO:0046085) | 2.66774586 |
| 63 | negative regulation of osteoblast proliferation (GO:0033689) | 2.66621571 |
| 64 | positive regulation of receptor recycling (GO:0001921) | 2.66132126 |
| 65 | interferon-gamma production (GO:0032609) | 2.64277382 |
| 66 | urea metabolic process (GO:0019627) | 2.64052211 |
| 67 | postsynaptic membrane organization (GO:0001941) | 2.61753532 |
| 68 | protein complex biogenesis (GO:0070271) | 2.61247294 |
| 69 | regulation of antigen processing and presentation (GO:0002577) | 2.59523799 |
| 70 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.59144048 |
| 71 | L-fucose catabolic process (GO:0042355) | 2.59136880 |
| 72 | fucose catabolic process (GO:0019317) | 2.59136880 |
| 73 | L-fucose metabolic process (GO:0042354) | 2.59136880 |
| 74 | C-terminal protein lipidation (GO:0006501) | 2.58776836 |
| 75 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58178470 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 2.56651407 |
| 77 | regulation of pigment cell differentiation (GO:0050932) | 2.56503350 |
| 78 | barbed-end actin filament capping (GO:0051016) | 2.55954544 |
| 79 | response to peptidoglycan (GO:0032494) | 2.55804566 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 2.54952028 |
| 81 | cellular response to exogenous dsRNA (GO:0071360) | 2.54427427 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 2.52214117 |
| 83 | intracellular pH reduction (GO:0051452) | 2.51841328 |
| 84 | neutrophil activation (GO:0042119) | 2.51540813 |
| 85 | leukocyte aggregation (GO:0070486) | 2.51434739 |
| 86 | urea cycle (GO:0000050) | 2.51009709 |
| 87 | cellular response to monoamine stimulus (GO:0071868) | 2.50730307 |
| 88 | cellular response to catecholamine stimulus (GO:0071870) | 2.50730307 |
| 89 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49985642 |
| 90 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49985642 |
| 91 | modulation by symbiont of host immune response (GO:0052553) | 2.49985642 |
| 92 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49985642 |
| 93 | modulation by symbiont of host defense response (GO:0052031) | 2.49985642 |
| 94 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49985642 |
| 95 | nitrogen cycle metabolic process (GO:0071941) | 2.49542410 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.49173625 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.49173625 |
| 98 | regulation of metalloenzyme activity (GO:0048552) | 2.48690674 |
| 99 | negative regulation of fibrinolysis (GO:0051918) | 2.47799134 |
| 100 | regulation of T cell mediated immunity (GO:0002709) | 2.47316073 |
| 101 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.46840153 |
| 102 | angiotensin maturation (GO:0002003) | 2.46816782 |
| 103 | positive regulation of interleukin-17 production (GO:0032740) | 2.44515103 |
| 104 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.44370482 |
| 105 | megakaryocyte development (GO:0035855) | 2.43402586 |
| 106 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.43365992 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.43188732 |
| 108 | activation of protein kinase A activity (GO:0034199) | 2.43072808 |
| 109 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43065882 |
| 110 | DNA deamination (GO:0045006) | 2.42862015 |
| 111 | T cell lineage commitment (GO:0002360) | 2.42510333 |
| 112 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.41788911 |
| 113 | fucosylation (GO:0036065) | 2.41143741 |
| 114 | cortical actin cytoskeleton organization (GO:0030866) | 2.41070402 |
| 115 | response to mercury ion (GO:0046689) | 2.40889236 |
| 116 | fructose metabolic process (GO:0006000) | 2.40265615 |
| 117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40234095 |
| 118 | negative regulation of viral entry into host cell (GO:0046597) | 2.39676274 |
| 119 | respiratory burst (GO:0045730) | 2.39578275 |
| 120 | stress fiber assembly (GO:0043149) | 2.38672030 |
| 121 | cellular response to epinephrine stimulus (GO:0071872) | 2.37450908 |
| 122 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.37296961 |
| 123 | response to interferon-alpha (GO:0035455) | 2.36957456 |
| 124 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.36817526 |
| 125 | ethanol metabolic process (GO:0006067) | 2.36571731 |
| 126 | detection of biotic stimulus (GO:0009595) | 2.35473287 |
| 127 | nucleotide transmembrane transport (GO:1901679) | 2.35248137 |
| 128 | adhesion of symbiont to host cell (GO:0044650) | 2.34772783 |
| 129 | virion attachment to host cell (GO:0019062) | 2.34772783 |
| 130 | low-density lipoprotein particle clearance (GO:0034383) | 2.33642462 |
| 131 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.32610739 |
| 132 | negative regulation of cell killing (GO:0031342) | 2.32610739 |
| 133 | negative regulation of fatty acid transport (GO:2000192) | 2.31957739 |
| 134 | centriole assembly (GO:0098534) | 2.31923528 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.31718319 |
| 136 | cellular response to interleukin-15 (GO:0071350) | 2.30783228 |
| 137 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.30608988 |
| 138 | C-terminal protein amino acid modification (GO:0018410) | 2.30274490 |
| 139 | peptide catabolic process (GO:0043171) | 2.30217040 |
| 140 | negative regulation of viral genome replication (GO:0045071) | 2.30187054 |
| 141 | lipoprotein transport (GO:0042953) | 2.29989142 |
| 142 | T cell homeostasis (GO:0043029) | 2.29642716 |
| 143 | positive regulation of macrophage cytokine production (GO:0060907) | 2.29209653 |
| 144 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.29093926 |
| 145 | secretory granule organization (GO:0033363) | 2.27929306 |
| 146 | energy homeostasis (GO:0097009) | 2.27634592 |
| 147 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.27481238 |
| 148 | regulation of relaxation of muscle (GO:1901077) | 2.27202773 |
| 149 | superoxide metabolic process (GO:0006801) | 2.27185789 |
| 150 | positive regulation of macrophage differentiation (GO:0045651) | 2.26592789 |
| 151 | hormone catabolic process (GO:0042447) | 2.26199226 |
| 152 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.25856789 |
| 153 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.25856789 |
| 154 | positive regulation of T cell migration (GO:2000406) | 2.25419213 |
| 155 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.25347890 |
| 156 | regulation of protein activation cascade (GO:2000257) | 2.24956031 |
| 157 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.22877766 |
| 158 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.20395610 |
| 159 | cell-cell junction maintenance (GO:0045217) | 2.19425214 |
| 160 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.19125929 |
| 161 | regulation of complement activation (GO:0030449) | 2.18521528 |
| 162 | L-amino acid import (GO:0043092) | 2.18421413 |
| 163 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.17665662 |
| 164 | actin filament polymerization (GO:0030041) | 2.15375818 |
| 165 | positive regulation of Rap GTPase activity (GO:0032854) | 2.14720443 |
| 166 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.13520039 |
| 167 | cardiac muscle contraction (GO:0060048) | 2.13074206 |
| 168 | positive regulation of lipid catabolic process (GO:0050996) | 2.12960696 |
| 169 | cortical cytoskeleton organization (GO:0030865) | 2.11484906 |
| 170 | regulation of early endosome to late endosome transport (GO:2000641) | 2.10889077 |
| 171 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.10055833 |
| 172 | regulation of fibrinolysis (GO:0051917) | 2.05815614 |
| 173 | mannose metabolic process (GO:0006013) | 2.05108617 |
| 174 | oxaloacetate metabolic process (GO:0006107) | 2.04821340 |
| 175 | regulation of macrophage cytokine production (GO:0010935) | 2.04783967 |
| 176 | response to monoamine (GO:0071867) | 2.04085065 |
| 177 | response to catecholamine (GO:0071869) | 2.04085065 |
| 178 | exogenous drug catabolic process (GO:0042738) | 2.03691943 |
| 179 | cerebellar granule cell differentiation (GO:0021707) | 2.03385891 |
| 180 | regulation of cholesterol homeostasis (GO:2000188) | 2.02222113 |
| 181 | diacylglycerol metabolic process (GO:0046339) | 2.02023761 |
| 182 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.02010959 |
| 183 | cell communication involved in cardiac conduction (GO:0086065) | 2.01397490 |
| 184 | omega-hydroxylase P450 pathway (GO:0097267) | 2.00157544 |
| 185 | cardiac myofibril assembly (GO:0055003) | 1.99391814 |
| 186 | positive regulation of triglyceride lipase activity (GO:0061365) | 1.99064804 |
| 187 | positive regulation of lipoprotein lipase activity (GO:0051006) | 1.99064804 |
| 188 | amyloid precursor protein catabolic process (GO:0042987) | 1.98302596 |
| 189 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.98217743 |
| 190 | endocytic recycling (GO:0032456) | 1.97591132 |
| 191 | modification by symbiont of host morphology or physiology (GO:0044003) | 1.96913502 |
| 192 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.96157739 |
| 193 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 1.94483173 |
| 194 | cell junction maintenance (GO:0034331) | 1.94190813 |
| 195 | glycosphingolipid catabolic process (GO:0046479) | 1.94160519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18737448 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.15929399 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11355823 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.11073927 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.10062794 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.85531851 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75199023 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.72884269 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55547260 |
| 10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.46723916 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43555800 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42342445 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37057956 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35643183 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.27717669 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.26661161 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.26429618 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23874781 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19437259 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15036662 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13334182 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.12950817 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09926957 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06952870 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05829424 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98852817 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96732469 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.93994597 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.93695769 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92972377 |
| 31 | KDM2B_26808549_Chip-Seq_K562_Human | 1.89561838 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89498663 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89420209 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89242278 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.89058074 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.87667425 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85589306 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83534104 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.80704857 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76335781 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.75851031 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75292481 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73439460 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69578812 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.69479626 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.69361684 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.69324578 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69082494 |
| 49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67787475 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65623313 |
| 51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.64985997 |
| 52 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.64421002 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63115132 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61596202 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61189583 |
| 56 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.60874313 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60656388 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60049311 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59546672 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59493913 |
| 61 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.58821209 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58383504 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57789589 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57108045 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53744823 |
| 66 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51642722 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.51348119 |
| 68 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.51163565 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50823976 |
| 70 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.49834161 |
| 71 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.49421948 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48328771 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47845716 |
| 74 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.47311556 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46446133 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46009675 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44264688 |
| 78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.43389053 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42789024 |
| 80 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.42222448 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41704975 |
| 82 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41107251 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40827336 |
| 84 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.40557896 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40279338 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39117315 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39067016 |
| 88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38581193 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37363735 |
| 90 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.37219513 |
| 91 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.37219513 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.36206468 |
| 93 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35243516 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33900479 |
| 95 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.32794982 |
| 96 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.32150144 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31650399 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.31501800 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31413382 |
| 100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31283469 |
| 101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31233081 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.31132809 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30021514 |
| 104 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.28688083 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28022587 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26327998 |
| 107 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.26145573 |
| 108 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25367137 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25195404 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25006985 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24502904 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23070020 |
| 113 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21987509 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.21619111 |
| 115 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21243528 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20747052 |
| 117 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20321436 |
| 118 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.19355451 |
| 119 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.19324275 |
| 120 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.18696008 |
| 121 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18435608 |
| 122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17903422 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17208686 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16509506 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16243374 |
| 126 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16193953 |
| 127 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.15717819 |
| 128 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14003947 |
| 129 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13833436 |
| 130 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13721265 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13430517 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13317174 |
| 133 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12220120 |
| 134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11387563 |
| 135 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10612839 |
| 136 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10582141 |
| 137 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09762109 |
| 138 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09707710 |
| 139 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09070174 |
| 140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09058768 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08976288 |
| 142 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08703623 |
| 143 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08590454 |
| 144 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08569671 |
| 145 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08448711 |
| 146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07698743 |
| 147 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06554287 |
| 148 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05531305 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05096938 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04921644 |
| 151 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04351892 |
| 152 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04316955 |
| 153 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04277825 |
| 154 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03601290 |
| 155 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03183997 |
| 156 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03149931 |
| 157 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02800928 |
| 158 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02581303 |
| 159 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02574561 |
| 160 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02517652 |
| 161 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01836483 |
| 162 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01651338 |
| 163 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01276989 |
| 164 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01236274 |
| 165 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01132535 |
| 166 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00289538 |
| 167 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99987266 |
| 168 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99514313 |
| 169 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99233195 |
| 170 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99116133 |
| 171 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99032949 |
| 172 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98690608 |
| 173 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97702922 |
| 174 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97352091 |
| 175 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97352091 |
| 176 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97016152 |
| 177 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96701534 |
| 178 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96629476 |
| 179 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96126188 |
| 180 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95197178 |
| 181 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94537197 |
| 182 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94450900 |
| 183 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91456766 |
| 184 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91070689 |
| 185 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89844935 |
| 186 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88147724 |
| 187 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87992860 |
| 188 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87947822 |
| 189 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86400721 |
| 190 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86299725 |
| 191 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85581241 |
| 192 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85409174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.30877930 |
| 2 | MP0005409_darkened_coat_color | 3.30273636 |
| 3 | MP0001188_hyperpigmentation | 3.15674133 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.13605068 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.94720742 |
| 6 | MP0009785_altered_susceptibility_to | 2.70216317 |
| 7 | MP0002876_abnormal_thyroid_physiology | 2.69068909 |
| 8 | MP0005671_abnormal_response_to | 2.67272897 |
| 9 | MP0009697_abnormal_copulation | 2.64044976 |
| 10 | MP0004858_abnormal_nervous_system | 2.62243611 |
| 11 | MP0009379_abnormal_foot_pigmentation | 2.59357349 |
| 12 | MP0003690_abnormal_glial_cell | 2.59084198 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.56759335 |
| 14 | MP0004147_increased_porphyrin_level | 2.53805813 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.51675857 |
| 16 | MP0003724_increased_susceptibility_to | 2.49709975 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.46776990 |
| 18 | MP0003303_peritoneal_inflammation | 2.46566207 |
| 19 | MP0005365_abnormal_bile_salt | 2.43162398 |
| 20 | MP0003329_amyloid_beta_deposits | 2.43091094 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.42709877 |
| 22 | MP0001986_abnormal_taste_sensitivity | 2.36928895 |
| 23 | MP0000015_abnormal_ear_pigmentation | 2.33529372 |
| 24 | MP0005360_urolithiasis | 2.31708032 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.10121670 |
| 26 | MP0005025_abnormal_response_to | 2.09005135 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.08525009 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 2.05010485 |
| 29 | MP0004270_analgesia | 2.04274045 |
| 30 | MP0009840_abnormal_foam_cell | 2.02135732 |
| 31 | MP0000685_abnormal_immune_system | 1.99005116 |
| 32 | MP0001790_abnormal_immune_system | 1.98919492 |
| 33 | MP0005387_immune_system_phenotype | 1.98919492 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.98391046 |
| 35 | MP0004130_abnormal_muscle_cell | 1.98376700 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.98340660 |
| 37 | MP0002723_abnormal_immune_serum | 1.95690973 |
| 38 | MP0003879_abnormal_hair_cell | 1.95003118 |
| 39 | MP0000751_myopathy | 1.93484323 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.93114909 |
| 41 | MP0004381_abnormal_hair_follicle | 1.92841510 |
| 42 | MP0002419_abnormal_innate_immunity | 1.91526523 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.90305887 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.90236178 |
| 45 | MP0001800_abnormal_humoral_immune | 1.89208613 |
| 46 | MP0001905_abnormal_dopamine_level | 1.82527956 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.82391492 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.82019344 |
| 49 | MP0001819_abnormal_immune_cell | 1.80862359 |
| 50 | MP0000604_amyloidosis | 1.70543246 |
| 51 | MP0003136_yellow_coat_color | 1.69424022 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.69241394 |
| 53 | MP0003868_abnormal_feces_composition | 1.68507514 |
| 54 | MP0005171_absent_coat_pigmentation | 1.68109441 |
| 55 | MP0002971_abnormal_brown_adipose | 1.65767860 |
| 56 | MP0005670_abnormal_white_adipose | 1.65566466 |
| 57 | MP0001958_emphysema | 1.62802707 |
| 58 | MP0003075_altered_response_to | 1.61171962 |
| 59 | MP0002095_abnormal_skin_pigmentation | 1.60889080 |
| 60 | MP0003828_pulmonary_edema | 1.60191667 |
| 61 | MP0003091_abnormal_cell_migration | 1.57597759 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.56944022 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.56090522 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.55080102 |
| 65 | MP0008004_abnormal_stomach_pH | 1.54312523 |
| 66 | MP0003880_abnormal_central_pattern | 1.53815819 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.50778080 |
| 68 | MP0005451_abnormal_body_composition | 1.49919400 |
| 69 | MP0003436_decreased_susceptibility_to | 1.47966448 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.46070070 |
| 71 | MP0001529_abnormal_vocalization | 1.44708445 |
| 72 | MP0002132_abnormal_respiratory_system | 1.41463410 |
| 73 | MP0006082_CNS_inflammation | 1.40491354 |
| 74 | MP0000716_abnormal_immune_system | 1.40315097 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 1.38843565 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.38290925 |
| 77 | MP0008260_abnormal_autophagy | 1.36370345 |
| 78 | MP0001873_stomach_inflammation | 1.36244425 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.36013093 |
| 80 | MP0002398_abnormal_bone_marrow | 1.34627278 |
| 81 | MP0000747_muscle_weakness | 1.33046737 |
| 82 | MP0005166_decreased_susceptibility_to | 1.32685567 |
| 83 | MP0004142_abnormal_muscle_tone | 1.28156962 |
| 84 | MP0002102_abnormal_ear_morphology | 1.27822910 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.27622780 |
| 86 | MP0002933_joint_inflammation | 1.27604240 |
| 87 | MP0002332_abnormal_exercise_endurance | 1.26972351 |
| 88 | MP0004087_abnormal_muscle_fiber | 1.24815417 |
| 89 | MP0005646_abnormal_pituitary_gland | 1.23814185 |
| 90 | MP0000920_abnormal_myelination | 1.20796784 |
| 91 | MP0001851_eye_inflammation | 1.18097296 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.16897256 |
| 93 | MP0002006_tumorigenesis | 1.16434587 |
| 94 | MP0006138_congestive_heart_failure | 1.16010483 |
| 95 | MP0000681_abnormal_thyroid_gland | 1.14360135 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 1.14344492 |
| 97 | MP0000689_abnormal_spleen_morphology | 1.13679224 |
| 98 | MP0010630_abnormal_cardiac_muscle | 1.13414967 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 1.11682852 |
| 100 | MP0005310_abnormal_salivary_gland | 1.10642407 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 1.10617317 |
| 102 | MP0001533_abnormal_skeleton_physiology | 1.08740772 |
| 103 | MP0001666_abnormal_nutrient_absorption | 1.08242589 |
| 104 | MP0003634_abnormal_glial_cell | 1.07280317 |
| 105 | MP0009115_abnormal_fat_cell | 1.06551503 |
| 106 | MP0003866_abnormal_defecation | 1.06510174 |
| 107 | MP0002429_abnormal_blood_cell | 1.06020180 |
| 108 | MP0003011_delayed_dark_adaptation | 1.04635825 |
| 109 | MP0002909_abnormal_adrenal_gland | 1.04176502 |
| 110 | MP0001845_abnormal_inflammatory_respons | 1.03651135 |
| 111 | MP0005076_abnormal_cell_differentiation | 1.03516657 |
| 112 | MP0005375_adipose_tissue_phenotype | 1.03089769 |
| 113 | MP0004742_abnormal_vestibular_system | 1.02722449 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 1.02316791 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 1.02044190 |
| 116 | MP0004036_abnormal_muscle_relaxation | 1.02019239 |
| 117 | MP0002735_abnormal_chemical_nociception | 1.01434434 |
| 118 | MP0004233_abnormal_muscle_weight | 1.01193695 |
| 119 | MP0000490_abnormal_crypts_of | 1.00562633 |
| 120 | MP0008874_decreased_physiological_sensi | 0.98926795 |
| 121 | MP0004883_abnormal_blood_vessel | 0.98595791 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.98526589 |
| 123 | MP0009764_decreased_sensitivity_to | 0.97723277 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.95140921 |
| 125 | MP0002722_abnormal_immune_system | 0.95082305 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.95037142 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.94632316 |
| 128 | MP0005535_abnormal_body_temperature | 0.94604638 |
| 129 | MP0002405_respiratory_system_inflammati | 0.93162885 |
| 130 | MP0005334_abnormal_fat_pad | 0.93131159 |
| 131 | MP0008469_abnormal_protein_level | 0.91497484 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.91275763 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.91032064 |
| 134 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90596893 |
| 135 | MP0008569_lethality_at_weaning | 0.90391958 |
| 136 | MP0001849_ear_inflammation | 0.90367069 |
| 137 | MP0001984_abnormal_olfaction | 0.89219148 |
| 138 | MP0004484_altered_response_of | 0.89131165 |
| 139 | MP0004084_abnormal_cardiac_muscle | 0.88613564 |
| 140 | MP0001502_abnormal_circadian_rhythm | 0.88464587 |
| 141 | MP0000750_abnormal_muscle_regeneration | 0.87741601 |
| 142 | MP0003279_aneurysm | 0.86957321 |
| 143 | MP0001486_abnormal_startle_reflex | 0.86765625 |
| 144 | MP0003635_abnormal_synaptic_transmissio | 0.85708237 |
| 145 | MP0010234_abnormal_vibrissa_follicle | 0.85471313 |
| 146 | MP0005397_hematopoietic_system_phenotyp | 0.84433191 |
| 147 | MP0001545_abnormal_hematopoietic_system | 0.84433191 |
| 148 | MP0004019_abnormal_vitamin_homeostasis | 0.83765442 |
| 149 | MP0001663_abnormal_digestive_system | 0.82139187 |
| 150 | MP0000749_muscle_degeneration | 0.81835584 |
| 151 | MP0002736_abnormal_nociception_after | 0.81567842 |
| 152 | MP0000759_abnormal_skeletal_muscle | 0.80982974 |
| 153 | MP0002063_abnormal_learning/memory/cond | 0.80426146 |
| 154 | MP0009780_abnormal_chondrocyte_physiolo | 0.79789804 |
| 155 | MP0002009_preneoplasia | 0.78809999 |
| 156 | MP0005330_cardiomyopathy | 0.78044175 |
| 157 | MP0002272_abnormal_nervous_system | 0.77922356 |
| 158 | MP0001440_abnormal_grooming_behavior | 0.77200983 |
| 159 | MP0010368_abnormal_lymphatic_system | 0.77150940 |
| 160 | MP0006276_abnormal_autonomic_nervous | 0.77022049 |
| 161 | MP0002064_seizures | 0.76729883 |
| 162 | MP0000609_abnormal_liver_physiology | 0.76572145 |
| 163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76561033 |
| 164 | MP0001968_abnormal_touch/_nociception | 0.76383485 |
| 165 | MP0001501_abnormal_sleep_pattern | 0.74691753 |
| 166 | MP0005388_respiratory_system_phenotype | 0.74197351 |
| 167 | MP0002133_abnormal_respiratory_system | 0.74197351 |
| 168 | MP0000858_altered_metastatic_potential | 0.73973332 |
| 169 | MP0005164_abnormal_response_to | 0.73909764 |
| 170 | MP0005423_abnormal_somatic_nervous | 0.73681476 |
| 171 | MP0001853_heart_inflammation | 0.73366492 |
| 172 | MP0002249_abnormal_larynx_morphology | 0.72761848 |
| 173 | MP0005165_increased_susceptibility_to | 0.72353368 |
| 174 | MP0005319_abnormal_enzyme/_coenzyme | 0.72074990 |
| 175 | MP0000678_abnormal_parathyroid_gland | 0.72043363 |
| 176 | MP0004510_myositis | 0.71711590 |
| 177 | MP0005058_abnormal_lysosome_morphology | 0.71361005 |
| 178 | MP0003186_abnormal_redox_activity | 0.71018314 |
| 179 | MP0002067_abnormal_sensory_capabilities | 0.70636468 |
| 180 | MP0002269_muscular_atrophy | 0.69974102 |
| 181 | MP0003453_abnormal_keratinocyte_physiol | 0.69953361 |
| 182 | MP0010386_abnormal_urinary_bladder | 0.69546317 |
| 183 | MP0001664_abnormal_digestion | 0.67972581 |
| 184 | MP0001963_abnormal_hearing_physiology | 0.67168940 |
| 185 | MP0000703_abnormal_thymus_morphology | 0.65054323 |
| 186 | MP0002998_abnormal_bone_remodeling | 0.64783279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 4.29340679 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 3.97505389 |
| 3 | Complement deficiency (HP:0004431) | 3.78878449 |
| 4 | Abnormality of complement system (HP:0005339) | 3.47527601 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.39112256 |
| 6 | Type I transferrin isoform profile (HP:0003642) | 3.32212689 |
| 7 | Patchy hypopigmentation of hair (HP:0011365) | 3.29562057 |
| 8 | Reduced antithrombin III activity (HP:0001976) | 3.25881820 |
| 9 | Aplastic anemia (HP:0001915) | 3.19741705 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.16459004 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.15783410 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.13956423 |
| 13 | IgM deficiency (HP:0002850) | 3.08558467 |
| 14 | White forelock (HP:0002211) | 3.06871407 |
| 15 | Nonprogressive disorder (HP:0003680) | 3.02843746 |
| 16 | Type 2 muscle fiber atrophy (HP:0003554) | 3.02681685 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99015063 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 2.98872636 |
| 19 | Bundle branch block (HP:0011710) | 2.97522761 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 2.96508439 |
| 21 | Myositis (HP:0100614) | 2.93200694 |
| 22 | Amyloidosis (HP:0011034) | 2.91564797 |
| 23 | Renal Fanconi syndrome (HP:0001994) | 2.87744107 |
| 24 | Obstructive sleep apnea (HP:0002870) | 2.82730735 |
| 25 | Thyroiditis (HP:0100646) | 2.82651050 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.78297245 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73938551 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 2.72553148 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71464498 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71464498 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 2.71464498 |
| 32 | Abnormal glycosylation (HP:0012345) | 2.71464498 |
| 33 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.68892003 |
| 34 | Glomerulonephritis (HP:0000099) | 2.65622528 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.63811128 |
| 36 | Muscle fiber atrophy (HP:0100295) | 2.63789742 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.62985027 |
| 38 | Difficulty running (HP:0009046) | 2.58446456 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.56654419 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56122105 |
| 41 | Exertional dyspnea (HP:0002875) | 2.53821614 |
| 42 | Meningitis (HP:0001287) | 2.53482024 |
| 43 | Cerebral aneurysm (HP:0004944) | 2.52290131 |
| 44 | Petechiae (HP:0000967) | 2.50939952 |
| 45 | Recurrent skin infections (HP:0001581) | 2.48259229 |
| 46 | Chronic diarrhea (HP:0002028) | 2.47319777 |
| 47 | Increased variability in muscle fiber diameter (HP:0003557) | 2.45066356 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.44606293 |
| 49 | Optic neuritis (HP:0100653) | 2.44606293 |
| 50 | Thyroid-stimulating hormone excess (HP:0002925) | 2.42252003 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.40537445 |
| 52 | Recurrent pneumonia (HP:0006532) | 2.40386729 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.40331918 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38717686 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38717686 |
| 56 | Thrombocytosis (HP:0001894) | 2.37510038 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.37502338 |
| 58 | Mitochondrial inheritance (HP:0001427) | 2.36883040 |
| 59 | Obstructive lung disease (HP:0006536) | 2.36470253 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36470253 |
| 61 | Ankle clonus (HP:0011448) | 2.36113803 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.34226385 |
| 63 | Type 1 muscle fiber predominance (HP:0003803) | 2.32633762 |
| 64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.32516794 |
| 65 | Hyporeflexia of lower limbs (HP:0002600) | 2.31958230 |
| 66 | Sudden death (HP:0001699) | 2.31704416 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.29120360 |
| 68 | B lymphocytopenia (HP:0010976) | 2.29120360 |
| 69 | Congenital sensorineural hearing impairment (HP:0008527) | 2.28512824 |
| 70 | Vasculitis (HP:0002633) | 2.28431564 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.28408572 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.28358675 |
| 73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.26186773 |
| 74 | Chromsome breakage (HP:0040012) | 2.24898690 |
| 75 | Hepatocellular necrosis (HP:0001404) | 2.24840699 |
| 76 | Stomatitis (HP:0010280) | 2.24472361 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.23060112 |
| 78 | Heart block (HP:0012722) | 2.22588582 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.21001678 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 2.20779269 |
| 81 | Chronic otitis media (HP:0000389) | 2.20350370 |
| 82 | Atrioventricular block (HP:0001678) | 2.19698236 |
| 83 | Peritonitis (HP:0002586) | 2.17917617 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.17343709 |
| 85 | Supranuclear gaze palsy (HP:0000605) | 2.16786807 |
| 86 | Abnormality of the prostate (HP:0008775) | 2.13642297 |
| 87 | Pancytopenia (HP:0001876) | 2.12570412 |
| 88 | Purpura (HP:0000979) | 2.12149982 |
| 89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11725182 |
| 90 | Muscle fiber splitting (HP:0003555) | 2.11523984 |
| 91 | IgG deficiency (HP:0004315) | 2.11125525 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.08765386 |
| 93 | Mediastinal lymphadenopathy (HP:0100721) | 2.07396036 |
| 94 | Severe combined immunodeficiency (HP:0004430) | 2.05895095 |
| 95 | Aneurysm (HP:0002617) | 2.05051040 |
| 96 | Vascular tortuosity (HP:0004948) | 2.04963465 |
| 97 | Hepatic necrosis (HP:0002605) | 2.03047386 |
| 98 | Febrile seizures (HP:0002373) | 2.02603711 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 2.02081343 |
| 100 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01871235 |
| 101 | Exercise-induced myalgia (HP:0003738) | 2.01778651 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.00668976 |
| 103 | Respiratory difficulties (HP:0002880) | 2.00066128 |
| 104 | Gingivitis (HP:0000230) | 1.99996672 |
| 105 | Recurrent viral infections (HP:0004429) | 1.99703836 |
| 106 | Orchitis (HP:0100796) | 1.98275560 |
| 107 | Abnormality of renal resorption (HP:0011038) | 1.97207059 |
| 108 | Recurrent sinusitis (HP:0011108) | 1.96346573 |
| 109 | Foot dorsiflexor weakness (HP:0009027) | 1.96104989 |
| 110 | Gastrointestinal stroma tumor (HP:0100723) | 1.95949849 |
| 111 | Neuronal loss in central nervous system (HP:0002529) | 1.94556370 |
| 112 | Nephritis (HP:0000123) | 1.93861651 |
| 113 | Increased connective tissue (HP:0009025) | 1.93447920 |
| 114 | Subaortic stenosis (HP:0001682) | 1.92860202 |
| 115 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92860202 |
| 116 | Arterial tortuosity (HP:0005116) | 1.91289035 |
| 117 | Decreased central vision (HP:0007663) | 1.91247973 |
| 118 | Renal cortical cysts (HP:0000803) | 1.90967253 |
| 119 | Increased CSF lactate (HP:0002490) | 1.90890196 |
| 120 | Reticulocytopenia (HP:0001896) | 1.90095894 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88612859 |
| 122 | Acute necrotizing encephalopathy (HP:0006965) | 1.87848446 |
| 123 | Mitral stenosis (HP:0001718) | 1.87611496 |
| 124 | Albinism (HP:0001022) | 1.87291490 |
| 125 | Dysostosis multiplex (HP:0000943) | 1.87001733 |
| 126 | Onion bulb formation (HP:0003383) | 1.86151885 |
| 127 | Prolonged neonatal jaundice (HP:0006579) | 1.86052108 |
| 128 | Hypoproteinemia (HP:0003075) | 1.85708734 |
| 129 | Abnormality of the foot musculature (HP:0001436) | 1.85474386 |
| 130 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85403303 |
| 131 | Prostate neoplasm (HP:0100787) | 1.84784535 |
| 132 | Joint hemorrhage (HP:0005261) | 1.84685136 |
| 133 | Epistaxis (HP:0000421) | 1.84045888 |
| 134 | Gingival bleeding (HP:0000225) | 1.83725574 |
| 135 | Weak cry (HP:0001612) | 1.83459582 |
| 136 | Distal lower limb amyotrophy (HP:0008944) | 1.83041976 |
| 137 | Polygenic inheritance (HP:0010982) | 1.82793302 |
| 138 | Xanthomatosis (HP:0000991) | 1.82739335 |
| 139 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.82362638 |
| 140 | Ventricular tachycardia (HP:0004756) | 1.82178529 |
| 141 | Lower limb amyotrophy (HP:0007210) | 1.80304884 |
| 142 | Neutropenia (HP:0001875) | 1.80100822 |
| 143 | Severe visual impairment (HP:0001141) | 1.80025313 |
| 144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78689663 |
| 145 | Abnormality of T cells (HP:0002843) | 1.78457823 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.77760868 |
| 147 | Growth hormone excess (HP:0000845) | 1.77094671 |
| 148 | Ventricular fibrillation (HP:0001663) | 1.76845007 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.76636540 |
| 150 | Microvesicular hepatic steatosis (HP:0001414) | 1.75612089 |
| 151 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.75287481 |
| 152 | Neonatal hypoglycemia (HP:0001998) | 1.74746930 |
| 153 | Apathy (HP:0000741) | 1.74709948 |
| 154 | Action tremor (HP:0002345) | 1.74658902 |
| 155 | Encephalitis (HP:0002383) | 1.74395312 |
| 156 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.73776878 |
| 157 | Mucopolysacchariduria (HP:0008155) | 1.73692245 |
| 158 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73692245 |
| 159 | Abnormality of eosinophils (HP:0001879) | 1.73044573 |
| 160 | Skin nodule (HP:0200036) | 1.72686888 |
| 161 | Autoimmune hemolytic anemia (HP:0001890) | 1.72405463 |
| 162 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72291389 |
| 163 | Myopathic facies (HP:0002058) | 1.72083074 |
| 164 | Rapidly progressive (HP:0003678) | 1.71713050 |
| 165 | Ventricular arrhythmia (HP:0004308) | 1.71348951 |
| 166 | Malnutrition (HP:0004395) | 1.71091077 |
| 167 | Aortic aneurysm (HP:0004942) | 1.70255302 |
| 168 | Thin bony cortex (HP:0002753) | 1.69979932 |
| 169 | Achilles tendon contracture (HP:0001771) | 1.68728569 |
| 170 | Turricephaly (HP:0000262) | 1.68686853 |
| 171 | Hyperparathyroidism (HP:0000843) | 1.67994526 |
| 172 | Cellulitis (HP:0100658) | 1.67871588 |
| 173 | Disinhibition (HP:0000734) | 1.66725234 |
| 174 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.66176474 |
| 175 | Depression (HP:0000716) | 1.65563445 |
| 176 | Axonal loss (HP:0003447) | 1.63980312 |
| 177 | Syncope (HP:0001279) | 1.61989617 |
| 178 | Myokymia (HP:0002411) | 1.60947292 |
| 179 | Hypercholesterolemia (HP:0003124) | 1.59544574 |
| 180 | Hammertoe (HP:0001765) | 1.58712874 |
| 181 | Decreased motor nerve conduction velocity (HP:0003431) | 1.56858644 |
| 182 | Mitral regurgitation (HP:0001653) | 1.56725779 |
| 183 | Increased cerebral lipofuscin (HP:0011813) | 1.55927537 |
| 184 | Nuclear cataract (HP:0100018) | 1.55560148 |
| 185 | Upper limb amyotrophy (HP:0009129) | 1.54351725 |
| 186 | Distal upper limb amyotrophy (HP:0007149) | 1.54351725 |
| 187 | Peripheral demyelination (HP:0011096) | 1.54284266 |
| 188 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.54185302 |
| 189 | Mutism (HP:0002300) | 1.54131324 |
| 190 | Stroke (HP:0001297) | 1.53638956 |
| 191 | Polycythemia (HP:0001901) | 1.53367899 |
| 192 | Diminished motivation (HP:0000745) | 1.53109086 |
| 193 | Papilledema (HP:0001085) | 1.52407031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.37358220 |
| 2 | STK16 | 3.75925597 |
| 3 | RIPK1 | 3.44739154 |
| 4 | TRIB3 | 3.14500473 |
| 5 | CASK | 2.96440352 |
| 6 | TXK | 2.91920065 |
| 7 | IRAK4 | 2.71032249 |
| 8 | ERN1 | 2.55207321 |
| 9 | MUSK | 2.32920595 |
| 10 | NME2 | 2.28860871 |
| 11 | TEC | 2.25530573 |
| 12 | BLK | 2.22436257 |
| 13 | CDK19 | 2.18307542 |
| 14 | MAP3K14 | 2.17325266 |
| 15 | ADRBK2 | 2.11542732 |
| 16 | KIT | 2.09013175 |
| 17 | MAP4K1 | 2.05519795 |
| 18 | IRAK3 | 1.94594613 |
| 19 | TTN | 1.69027212 |
| 20 | DMPK | 1.67831220 |
| 21 | IKBKE | 1.67528171 |
| 22 | NTRK1 | 1.62178069 |
| 23 | KSR2 | 1.56280767 |
| 24 | LATS2 | 1.48405933 |
| 25 | NLK | 1.47350310 |
| 26 | MAP3K12 | 1.47317519 |
| 27 | MAP2K7 | 1.45731034 |
| 28 | RIPK4 | 1.45404028 |
| 29 | SIK1 | 1.44992159 |
| 30 | ICK | 1.44168401 |
| 31 | FES | 1.42879591 |
| 32 | MARK2 | 1.42600527 |
| 33 | PDGFRA | 1.42031110 |
| 34 | MAP2K3 | 1.38589671 |
| 35 | FRK | 1.34822854 |
| 36 | CDC42BPA | 1.33176795 |
| 37 | PAK6 | 1.31713233 |
| 38 | EIF2AK2 | 1.31432240 |
| 39 | MKNK2 | 1.30345956 |
| 40 | BTK | 1.30053891 |
| 41 | MAP3K13 | 1.29368737 |
| 42 | IRAK1 | 1.28564585 |
| 43 | STK39 | 1.27875582 |
| 44 | FGFR4 | 1.26358300 |
| 45 | TNK2 | 1.24894103 |
| 46 | CLK1 | 1.24240258 |
| 47 | YES1 | 1.23621358 |
| 48 | SYK | 1.23167193 |
| 49 | ARAF | 1.22792896 |
| 50 | GRK7 | 1.19765524 |
| 51 | BMPR1B | 1.19060529 |
| 52 | PDPK1 | 1.19030533 |
| 53 | PKN2 | 1.18422583 |
| 54 | EPHA4 | 1.14600189 |
| 55 | SGK3 | 1.14466624 |
| 56 | CAMKK2 | 1.13492020 |
| 57 | TAOK2 | 1.12741700 |
| 58 | TAOK1 | 1.12567974 |
| 59 | MAP3K1 | 1.10755535 |
| 60 | OXSR1 | 1.09326349 |
| 61 | IKBKB | 1.08275073 |
| 62 | LYN | 1.06720899 |
| 63 | GRK1 | 1.06409560 |
| 64 | CSF1R | 1.04155985 |
| 65 | MAPKAPK5 | 1.03829194 |
| 66 | BMPR2 | 1.03728441 |
| 67 | MAP3K9 | 1.03718639 |
| 68 | PRPF4B | 1.03620546 |
| 69 | MOS | 1.03210135 |
| 70 | EEF2K | 1.01129478 |
| 71 | DDR2 | 1.00726233 |
| 72 | CAMK1G | 1.00433435 |
| 73 | MAP3K6 | 0.99600821 |
| 74 | CAMKK1 | 0.98406935 |
| 75 | CAMK1D | 0.96913250 |
| 76 | DYRK1B | 0.96856778 |
| 77 | VRK1 | 0.96607327 |
| 78 | TBK1 | 0.94980207 |
| 79 | CDK12 | 0.94753121 |
| 80 | PRKD3 | 0.94635920 |
| 81 | PIK3CG | 0.93378403 |
| 82 | MARK1 | 0.92582458 |
| 83 | MAP3K11 | 0.91337227 |
| 84 | MKNK1 | 0.90421715 |
| 85 | ZAP70 | 0.90079079 |
| 86 | IRAK2 | 0.89520070 |
| 87 | PTK6 | 0.88355032 |
| 88 | LCK | 0.87176361 |
| 89 | PDK1 | 0.86936629 |
| 90 | LRRK2 | 0.86389912 |
| 91 | NEK6 | 0.85863304 |
| 92 | TAOK3 | 0.85373141 |
| 93 | MAPK12 | 0.85317289 |
| 94 | EPHB2 | 0.84874097 |
| 95 | MAP3K3 | 0.84716819 |
| 96 | PIM2 | 0.84511806 |
| 97 | SGK2 | 0.84463787 |
| 98 | ZAK | 0.84312216 |
| 99 | EIF2AK3 | 0.83472807 |
| 100 | ROCK2 | 0.83043824 |
| 101 | TGFBR2 | 0.82974301 |
| 102 | SGK223 | 0.82485370 |
| 103 | SGK494 | 0.82485370 |
| 104 | TLK1 | 0.82054055 |
| 105 | NUAK1 | 0.81666047 |
| 106 | RET | 0.81574999 |
| 107 | SIK3 | 0.80990401 |
| 108 | MAPK13 | 0.80717997 |
| 109 | TYK2 | 0.80356736 |
| 110 | PRKD2 | 0.79628481 |
| 111 | PTK2 | 0.79050908 |
| 112 | MAP3K2 | 0.78120988 |
| 113 | NEK9 | 0.77819500 |
| 114 | MAPK15 | 0.77729770 |
| 115 | JAK2 | 0.77025130 |
| 116 | MAP2K4 | 0.76745378 |
| 117 | RPS6KA2 | 0.74103576 |
| 118 | NTRK3 | 0.74010491 |
| 119 | CDK3 | 0.72848285 |
| 120 | NTRK2 | 0.72595805 |
| 121 | PRKG2 | 0.72502572 |
| 122 | DAPK2 | 0.72208467 |
| 123 | FGR | 0.71821191 |
| 124 | JAK1 | 0.71469675 |
| 125 | FLT3 | 0.70234464 |
| 126 | TRPM7 | 0.69458184 |
| 127 | MYLK | 0.68381252 |
| 128 | MAPK7 | 0.68375908 |
| 129 | JAK3 | 0.67210395 |
| 130 | OBSCN | 0.66082150 |
| 131 | MTOR | 0.65984187 |
| 132 | PDGFRB | 0.65817848 |
| 133 | WNK1 | 0.65671088 |
| 134 | MAP3K7 | 0.65474552 |
| 135 | PRKCH | 0.65464700 |
| 136 | INSRR | 0.64484965 |
| 137 | ABL2 | 0.63425121 |
| 138 | CAMK1 | 0.62614295 |
| 139 | BCR | 0.61328019 |
| 140 | STK38 | 0.61220600 |
| 141 | PKN1 | 0.60891678 |
| 142 | PRKCQ | 0.60668462 |
| 143 | UHMK1 | 0.60347344 |
| 144 | KSR1 | 0.60016123 |
| 145 | PRKD1 | 0.57742943 |
| 146 | CDK5 | 0.57379472 |
| 147 | CSNK1G3 | 0.56705005 |
| 148 | FGFR3 | 0.56493461 |
| 149 | MST4 | 0.55532962 |
| 150 | WNK4 | 0.55508406 |
| 151 | SMG1 | 0.54397512 |
| 152 | HCK | 0.54231766 |
| 153 | STK11 | 0.53815783 |
| 154 | TYRO3 | 0.52884460 |
| 155 | RPS6KL1 | 0.52657722 |
| 156 | RPS6KC1 | 0.52657722 |
| 157 | PRKAA2 | 0.52013685 |
| 158 | PLK4 | 0.51936618 |
| 159 | ERBB2 | 0.51802126 |
| 160 | PIK3CA | 0.51647666 |
| 161 | CSK | 0.50480378 |
| 162 | CAMK2B | 0.49414963 |
| 163 | CSNK1G1 | 0.46240298 |
| 164 | MAP2K6 | 0.46164056 |
| 165 | PRKCE | 0.45766502 |
| 166 | ITK | 0.45066266 |
| 167 | PBK | 0.44476449 |
| 168 | SRPK1 | 0.44190961 |
| 169 | CSNK1A1L | 0.43478125 |
| 170 | MATK | 0.43114163 |
| 171 | CHUK | 0.40648714 |
| 172 | CAMK2D | 0.39182877 |
| 173 | PRKCD | 0.37897942 |
| 174 | EPHB1 | 0.37803534 |
| 175 | TIE1 | 0.37740797 |
| 176 | EIF2AK1 | 0.36823871 |
| 177 | CAMK2G | 0.36777611 |
| 178 | MAP2K2 | 0.36762807 |
| 179 | BRAF | 0.35365856 |
| 180 | STK24 | 0.34375620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.96226816 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77106059 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.74592261 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.69782943 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.45187817 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42638276 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.09635540 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97542585 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95980033 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.93486573 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90674260 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86218453 |
| 13 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.84013146 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82822553 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.82766123 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72992287 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.71345443 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64813990 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62776043 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61657722 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.61515698 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59349496 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.57871935 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56372046 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54510515 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51606053 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.51283063 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50968359 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50934268 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.48157197 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46412557 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.45231630 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44419728 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43598735 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42617609 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40676960 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40033578 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.38016735 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35938590 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33212588 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30119251 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26124912 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25739517 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23579276 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.21448500 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20201814 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19989219 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 1.17769835 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.17531823 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16572704 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14566887 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14323567 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13622471 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.11815484 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10903736 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09795846 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09483134 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09159962 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09093460 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08374553 |
| 61 | Malaria_Homo sapiens_hsa05144 | 1.08229117 |
| 62 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08068928 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06917584 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06366594 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06049368 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04989717 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03576255 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 1.02916816 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02697864 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01492435 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01024471 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00108007 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.98701768 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.98301520 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98065133 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97920179 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.97434534 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96305123 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95653425 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95069088 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93997716 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90722416 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90325404 |
| 84 | * Purine metabolism_Homo sapiens_hsa00230 | 0.90114803 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.89428153 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.88612007 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87754281 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87598834 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85416297 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85326103 |
| 91 | DNA replication_Homo sapiens_hsa03030 | 0.85177318 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83758267 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83384860 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83282236 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82247758 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82205578 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82021154 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81040090 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78421965 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76937751 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.76843493 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76756756 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76457512 |
| 104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75501529 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75429038 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75181906 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72542777 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72329790 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.70146739 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69136188 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69107236 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69087713 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67949876 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67340215 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67125072 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66184513 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65832474 |
| 118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65631154 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65507970 |
| 120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.65313210 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65218162 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65177797 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.64990728 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.64970763 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64898263 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64878781 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64762258 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64377435 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64183490 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63253597 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63171045 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63162776 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63110536 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62740925 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62700866 |
| 136 | Proteasome_Homo sapiens_hsa03050 | 0.62513037 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61302563 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.60997173 |
| 139 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60813016 |
| 140 | Influenza A_Homo sapiens_hsa05164 | 0.60694625 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59773115 |
| 142 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59593928 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58296397 |
| 144 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57826394 |
| 145 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57515479 |
| 146 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56715707 |
| 147 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56321180 |
| 148 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55656508 |
| 149 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55155766 |
| 150 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55145525 |
| 151 | Lysosome_Homo sapiens_hsa04142 | 0.54080909 |
| 152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53183152 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.53170428 |
| 154 | Phagosome_Homo sapiens_hsa04145 | 0.53125015 |
| 155 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53057319 |
| 156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52730973 |
| 157 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52491097 |
| 158 | Focal adhesion_Homo sapiens_hsa04510 | 0.52328840 |
| 159 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52104067 |
| 160 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51860489 |
| 161 | Endocytosis_Homo sapiens_hsa04144 | 0.51842753 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51658949 |
| 163 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51650057 |
| 164 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51628709 |
| 165 | Gap junction_Homo sapiens_hsa04540 | 0.51580740 |
| 166 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51192332 |
| 167 | Taste transduction_Homo sapiens_hsa04742 | 0.49843051 |
| 168 | Phototransduction_Homo sapiens_hsa04744 | 0.49228738 |
| 169 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48496093 |
| 170 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48108694 |
| 171 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47677482 |
| 172 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46314692 |
| 173 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44410652 |
| 174 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43883214 |
| 175 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41876654 |
| 176 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39905677 |
| 177 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37715388 |
| 178 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37381045 |
| 179 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36128765 |
| 180 | Hepatitis B_Homo sapiens_hsa05161 | 0.36060763 |
| 181 | Legionellosis_Homo sapiens_hsa05134 | 0.35117168 |

